메뉴 건너뛰기




Volumn 4, Issue 12 SUPPL. 2, 2000, Pages

The cost-effectiveness of screening for latent tuberculosis infection

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; ISONIAZID PLUS RIFAMPICIN; RIFATER;

EID: 0034517794     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (23)

References (22)
  • 1
    • 0015062232 scopus 로고
    • Chemoprophylaxis of tuberculosis: When is the benefit worth the risk and cost?
    • (1971) Ann Intern Med , vol.74 , pp. 761-770
    • Moulding, T.1
  • 2
    • 0016304434 scopus 로고
    • Preventive therapy of tuberculous infection
    • (1974) Am Rev Respir Dis , vol.110 , pp. 371-374
  • 6
    • 0025650362 scopus 로고
    • Decision analysis, public health policy, and isoniazid chemoprophylaxis for young adult tuberculin skin reactors
    • (1990) Arch Intern Med , vol.150 , pp. 2517-2522
    • Colice, G.L.1
  • 16
    • 0032533886 scopus 로고    scopus 로고
    • Short-course prophylaxis against tuberculosis in HIV-infected persons. A decision and cost-effectiveness analysis
    • (1998) Ann Intern Med , vol.129 , pp. 779-786
    • Rose, D.N.1
  • 21
    • 0002293558 scopus 로고    scopus 로고
    • The general health policy model: An integrated approach
    • Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott-Raven Publishers
    • (1996) , pp. 309-322
    • Kaplan, R.M.1    Anderson, J.P.2
  • 22
    • 4244138308 scopus 로고    scopus 로고
    • Quality-of-life estimates for tuberculosis
    • 30th International Union Against Tuberculosis & Lung Disease World Conference on Lung Health. Madrid, Spain. September 1999. Abstract Int J Tuberc Lung Dis
    • (1999) , vol.3 , Issue.SUPPL.1
    • Nguyen, C.1    Taylor, Z.2    Qualls, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.